Protagonist Therapeutics, Inc (PTGX)

Typically moves ±6.59% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-06 APPROXIMATE

Protagonist Therapeutics, Inc (PTGX) has a 39-report earnings history dating back to Nov 14, 2016. Its average absolute post-earnings move is ±6.59%, and 56.4% of those reactions were positive. Its largest post-earnings gain was +83.7% (May 07, 2020) and its largest decline was -22.38% (May 09, 2018). The next earnings report is predicted for 2026-08-06 (approximate).

Earnings reactions

How PTGX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.59%

Positive %

56.4%

Negative %

43.6%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 05, 2026	☽ POST	+4.88%	open_in_new
Feb 25, 2026	☽ POST	+1.48%	open_in_new
Nov 06, 2025	☽ POST	-0.3%	open_in_new
Aug 06, 2025	☽ POST	-5.39%	open_in_new
May 06, 2025	☽ POST	+2.57%	open_in_new
Feb 21, 2025	☀ PRE	+0.68%	open_in_new
Nov 07, 2024	☽ POST	-2.9%	open_in_new
Aug 06, 2024	☀ PRE	+1.17%	open_in_new
May 07, 2024	☽ POST	+5.12%	open_in_new
Feb 27, 2024	☽ POST	+2.84%	open_in_new
Nov 02, 2023	☽ POST	+8.05%	open_in_new
Aug 03, 2023	☽ POST	+3.28%	open_in_new
May 04, 2023	☽ POST	+5.13%	open_in_new
Mar 15, 2023	☽ POST	-3.74%	open_in_new
Nov 08, 2022	☽ POST	-0.39%	open_in_new
Aug 04, 2022	☽ POST	-2.13%	open_in_new
May 04, 2022	☽ POST	-0.2%	open_in_new
Feb 28, 2022	☽ POST	+8.11%	open_in_new
Nov 03, 2021	☽ POST	+2.82%	open_in_new
Aug 04, 2021	☽ POST	-1.61%	open_in_new
May 04, 2021	☽ POST	-0.85%	open_in_new
Mar 10, 2021	☽ POST	+4.09%	open_in_new
Nov 04, 2020	☽ POST	+8.62%	open_in_new
Aug 06, 2020	☽ POST	+9.18%	open_in_new
May 07, 2020	☽ POST	+83.7%	open_in_new
Mar 10, 2020	☽ POST	-6.16%	open_in_new
Nov 06, 2019	☽ POST	-14.4%	open_in_new
Aug 07, 2019	☀ PRE	+2.17%	open_in_new
May 08, 2019	☀ PRE	+6.24%	open_in_new
Mar 12, 2019	☽ POST	-1.46%	open_in_new
Nov 06, 2018	☽ POST	+4.14%	open_in_new
Aug 07, 2018	☽ POST	-0.64%	open_in_new
May 09, 2018	☽ POST	-22.38%	open_in_new
Mar 07, 2018	☽ POST	-3.16%	open_in_new
Nov 06, 2017	☽ POST	+8.57%	open_in_new
Aug 08, 2017	☽ POST	-8.69%	open_in_new
May 10, 2017	☽ POST	+7.67%	open_in_new
Mar 07, 2017	☽ POST	+0.89%	open_in_new
Nov 14, 2016	☽ POST	-1.08%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.59%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 25 →

Funds holding

$2443501518

Total value held

Buying

17 added · 7 reduced

Blackrock, Inc.

$1030745507 +0.65%

State Street Corp

$328505345 -2.59%

Janus Henderson Group Plc

$304866424 NEW BUY

Johnson & Johnson

$258143888 Held

Bank Of America Corp /De/

$136538743 +49.32%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260625	open_in_new SEC.gov
144	20260623	open_in_new SEC.gov
8-K	20260618	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
144	20260610	open_in_new SEC.gov
4	20260601	open_in_new SEC.gov
144	20260529	open_in_new SEC.gov
4/A	20260514	open_in_new SEC.gov
144	20260508	open_in_new SEC.gov
144	20260507	open_in_new SEC.gov

Frequently asked about PTGX earnings

When does Protagonist Therapeutics, Inc report earnings next? expand_more

Protagonist Therapeutics, Inc (PTGX)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does PTGX stock move after earnings? expand_more

Over 39 reports, PTGX has moved an average of ±6.59% the session after earnings, closing higher 56.4% of the time.

What was PTGX's biggest post-earnings move? expand_more

PTGX's largest post-earnings gain on record was +83.7% on May 07, 2020, and its largest decline was -22.38% on May 09, 2018.

Where can I find Protagonist Therapeutics, Inc's SEC filings? expand_more

All of Protagonist Therapeutics, Inc's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.